All In MedTech

FDA Clearance Tracker · P140003-S094

Impella 5.5 with SmartAssist

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 4, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 4, 2022

Approved

Time to decision

264 days

Received Jan 13, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140003-S094
Device name
Impella 5.5 with SmartAssist
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Jan 13, 2022
Decided
Oct 4, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

Approval for integrating the purge sidearm within the patient cable and changing the catheter repositioning securement type

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.